| 000 | 01449 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516220502.0 | ||
| 264 | 0 | _c20141028 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a2326-5205 | ||
| 024 | 7 |
_a10.1002/art.38741 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchmeling, Heinrike | |
| 245 | 0 | 0 |
_aEfficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry. _h[electronic resource] |
| 260 |
_bArthritis & rheumatology (Hoboken, N.J.) _cSep 2014 |
||
| 300 |
_a2580-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Juvenile _xdrug therapy |
| 650 | 0 | 4 |
_aBiological Products _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMinden, Kirsten | |
| 700 | 1 | _aFoeldvari, Ivan | |
| 700 | 1 | _aGanser, Gerd | |
| 700 | 1 | _aHospach, Tony | |
| 700 | 1 | _aHorneff, Gerd | |
| 773 | 0 |
_tArthritis & rheumatology (Hoboken, N.J.) _gvol. 66 _gno. 9 _gp. 2580-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.38741 _zAvailable from publisher's website |
| 999 |
_c23931704 _d23931704 |
||